Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 5010-5014, December 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ray, P. K.
Right arrow Articles by Bassett, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ray, P. K.
Right arrow Articles by Bassett, J. G.

Ability of Nonviable Staphylococcus aureus Cowan I To Bind Ionized Calcium in Vitro and ex Vivo in an Extracorporeal Perfusion System1

Prasanta K. Ray2, Syamal Raychaudhuri, Denise McLaughlin, Alexander Idiculla, Jonathan E. Rhoads, Jr. and James G. Bassett

Department of Surgery, Alma Dea Morani Laboratory of Surgical Immunobiology, The Medical College of Pennsylvania and Hospital, Philadelphia, Pennsylvania 19129

During immunoadsorption of plasma immunoglobulin G (IgG) and/or its complexes, using nonviable Staphylococcus aureus Cowan I (SA) as an immunoadsorbent, we observed a consistent drop in plasma calcium during every immunoadsorption procedure. The percentage of decrease in plasma calcium was directly dependent on the amount of SA adsorbent present. Although SA can bind both IgG and calcium, the degree of binding of IgG was greater than that of calcium. Calcium could not be detected in the IgG fraction of the plasma. SA, however, could bind an appreciable amount of ionized calcium.

Extracorporeal perfusion of plasma over SA greatly decreased plasma calcium in a hypercalcemic patient, indicating the feasibility of this method in such patients. Questions concerning the significance of lowering calcium levels as a concomitant of other effects observed in cancer patients undergoing immunoadsorption therapy using SA evolve from the above and become a new focus for attention.

1 The authors gratefully acknowledge the financial help received from the Fannie E. Rippel Foundation, the R. J. Reynolds Industries, Inc., and the W. W. Smith Charitable Trust to carry out this investigation.

2 To whom requests for reprints should be addressed, at Department of Surgery and Microbiology, Alma Dea Morani Laboratory of Surgical Immunobiology, The Medical College of Pennsylvania and Hospital, 3300 Henry Avenue, Philadelphia, Pa. 19129.

Received 7/ 6/81. Accepted 9/ 9/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.